153 related articles for article (PubMed ID: 36042605)
1. Massive pericardial effusion due to chronic active Epstein-Barr virus infection successfully treated with PD-1 blockade: A case report.
Pi Y; Wang J; Wang Z
Medicine (Baltimore); 2022 Aug; 101(34):e30298. PubMed ID: 36042605
[TBL] [Abstract][Full Text] [Related]
2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
3. [Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation].
Matsui S; Takeda Y; Isshiki Y; Yamazaki A; Nakao S; Takaishi K; Nagao Y; Hasegawa N; Togasaki E; Shimizu R; Kawajiri C; Sakai S; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Iseki T; Imadome K; Nakaseko C
Rinsho Ketsueki; 2016 May; 57(5):624-9. PubMed ID: 27263789
[TBL] [Abstract][Full Text] [Related]
4. PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
Song Y; Wang J; Wang Y; Wu L; You Y; Song D; Chen L; Meng G; He X; Cui T; Wang X; Yin Q; Wang Z
Clin Microbiol Infect; 2023 Jun; 29(6):796.e7-796.e13. PubMed ID: 36702399
[TBL] [Abstract][Full Text] [Related]
5. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
[TBL] [Abstract][Full Text] [Related]
6. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
[TBL] [Abstract][Full Text] [Related]
7. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
You Y; Wang J; Wang Z
Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
[TBL] [Abstract][Full Text] [Related]
9. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
Shibata S; Takiuchi Y; Kawasaki N; Okamoto Y; Inano S; Fukunaga A; Tabata S; Arai A; Imadome KI; Kitano T
Int J Hematol; 2022 Apr; 115(4):595-599. PubMed ID: 35001347
[TBL] [Abstract][Full Text] [Related]
10. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
[TBL] [Abstract][Full Text] [Related]
11. Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
Ma Y; Zhang P; Bao Y; Luo H; Wang J; Huang L; Zheng M
Front Immunol; 2023; 14():1093719. PubMed ID: 36969150
[TBL] [Abstract][Full Text] [Related]
13. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
[TBL] [Abstract][Full Text] [Related]
14. Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
Aihara Y; Moriya K; Shimozato N; Nagamatsu S; Kobayashi S; Uejima M; Matsuo H; Ishida E; Yagi H; Nakatani T; Yoshiji H; Kikuchi E
BMC Gastroenterol; 2021 Jan; 21(1):6. PubMed ID: 33407170
[TBL] [Abstract][Full Text] [Related]
15. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report.
Ma Y; Bao Y; Zheng M
BMC Infect Dis; 2023 Jul; 23(1):453. PubMed ID: 37420238
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
18. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
Wang J; Su M; Wei N; Yan H; Zhang J; Gong Y; Wu L; Suolitiken D; Pi Y; Song D; Chen L; Liu H; Yang S; Wang X; Wang Z
Blood; 2024 Jan; 143(1):32-41. PubMed ID: 37824804
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]